- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Type 2 Diabetes With Non-alcoholic Fatty Liver (NAFLD) in United States
Total 675 results
-
Boehringer IngelheimRecruitingObesity | Non-Alcoholic SteatoHepatitis (NASH)United States
-
Georgetown UniversityCompletedNonalcoholic SteatohepatitisUnited States
-
Mayo ClinicUniversity of Florida; Orphan MedicalCompleted
-
University of California, San DiegoDaiichi Sankyo, Inc.CompletedNonalcoholic SteatohepatitisUnited States
-
Johns Hopkins Bloomberg School of Public HealthBaylor College of Medicine; National Institute of Diabetes and Digestive and... and other collaboratorsRecruiting
-
PfizerCompleted
-
University of OxfordCompletedNon-alcoholic Fatty Liver DiseaseUnited Kingdom
-
Duke UniversityCompletedLiver Diseases | Nonalcoholic Steatohepatitis (NASH) | Nonalcoholic Steatohepatitis | Nonalcoholic Fatty LiverUnited States
-
MediciNovaCompletedNon-alcoholic Fatty Liver Disease | Hypercholesterolemia | Hypertriglyceridemia | Non-alcoholic SteatohepatitisUnited States
-
University of NottinghamCompletedNon-alcoholic Fatty Liver DiseaseUnited Kingdom
-
Dartmouth-Hitchcock Medical CenterCompletedHepatic Steatosis | Nonalcoholic Fatty Liver Disease | SteatohepatitisUnited States
-
PerspectumKing's College Hospital NHS Trust; University of Coimbra; Liverpool University... and other collaboratorsCompletedMetabolic Syndrome | NAFLD | NASH - Nonalcoholic SteatohepatitisUnited Kingdom, Germany, Netherlands, Portugal
-
University of EdinburghUniversity of Amsterdam; University of StrathclydeCompletedNon-alcoholic Fatty Liver DiseaseUnited Kingdom
-
Antipodean Pharmaceuticals, Inc.TerminatedNon-alcoholic Fatty Liver DiseaseUnited Kingdom
-
Ohio State UniversityCompletedMetabolic Syndrome | Non-alcoholic Fatty LiverUnited States
-
Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Albert...Not yet recruitingInsulin Resistance | Prediabetic State | Overweight and Obesity | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Boston UniversityGlaxoSmithKlineTerminatedFatty Liver | Non-alcoholic Fatty Liver DiseaseUnited States
-
GlaxoSmithKlineRecruitingNon-alcoholic Fatty Liver DiseaseUnited States
-
University of NottinghamNottingham University Hospitals NHS Trust; National Institute for Health Research...CompletedInsulin Resistance | Non-Alcoholic Fatty Liver DiseaseUnited Kingdom
-
UNC Nutrition Research InstituteCompletedUtilizing Non-Invasive Fibroscan® Technology to Identify Genetic Markers for Fatty Liver ProgressionNon-alcoholic Fatty Liver DiseaseUnited States
-
National Institute of Diabetes and Digestive and...University of California, San Diego; The Cleveland Clinic; Duke University; University... and other collaboratorsRecruitingNonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States
-
Emirates Health Services (EHS)Mayo ClinicCompletedObesity | Non-Alcoholic Fatty Liver DiseaseUnited Arab Emirates
-
EchosensCompletedNon-alcoholic Fatty Liver DiseaseUnited Kingdom
-
Columbia UniversityUniversity of California, BerkeleyRecruitingInsulin Resistance | Prediabetic State | Overweight and Obesity | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Enanta Pharmaceuticals, IncCovanceCompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Enanta Pharmaceuticals, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Ohio State UniversityActive, not recruiting
-
Massachusetts General HospitalRecruitingNASH - Nonalcoholic SteatohepatitisUnited States
-
Meridian Bioscience, Inc.Bristol-Myers SquibbCompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH)United States
-
Navidea BiopharmaceuticalsCompletedNonalcoholic Steatohepatitis | NASH - Nonalcoholic SteatohepatitisUnited States
-
Conatus Pharmaceuticals Inc.CompletedNon-alcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States
-
Boehringer IngelheimCompletedNon-alcoholic Fatty Liver DiseaseUnited States, Spain, United Kingdom, Belgium, Canada, Germany, Netherlands, France, Ireland
-
Madrigal Pharmaceuticals, Inc.RecruitingNon-Alcoholic Fatty Liver DiseaseUnited States, Puerto Rico
-
Madrigal Pharmaceuticals, Inc.CompletedNon-Alcoholic Fatty Liver DiseaseUnited States, Puerto Rico
-
Brooke Army Medical CenterUnknownNonalcoholic Fatty Liver Disease | Nonalcoholic SteatohepatitisUnited States
-
Metacrine, Inc.Completed
-
PfizerCompletedNonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis With Liver FibrosisHong Kong, United States, Taiwan, Puerto Rico, China, Canada, Korea, Republic of, Bulgaria, Japan, India, Poland, Slovakia
-
Conatus Pharmaceuticals Inc.CompletedLiver Diseases | Fibrosis | Non-alcoholic SteatohepatitisUnited States, Spain, Germany
-
AstraZenecaTerminatedNonalcoholic SteatohapatitisUnited States
-
Rivus Pharmaceuticals, Inc.CompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Rivus Pharmaceuticals, Inc.CompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Enanta Pharmaceuticals, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Icahn School of Medicine at Mount SinaiNational Institutes of Health (NIH)CompletedNASH - Nonalcoholic Steatohepatitis | Steatosis of LiverUnited States
-
Manal AbdelmalekCompletedNonalcoholic SteatohepatitisUnited States
-
Emory UniversityCenter for Cystic Fibrosis and Airways Disease ResearchCompleted
-
Vanderbilt UniversityEnrolling by invitationNonalcoholic Fatty Liver DiseaseUnited States
-
University of LiverpoolImperial College London; Royal Liverpool University Hospital; University of Surrey and other collaboratorsUnknownNon Alcoholic Fatty Liver DiseaseUnited Kingdom
-
Second GenomeTerminatedNonalcoholic SteatohepatitisUnited States
-
University of California, San FranciscoCompleted